Diabetes Education News

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM, about situations in which an ultra-long-acting insulin may be a good choice.

Adults who achieve type 2 diabetes remission are less likely to develop chronic kidney disease and cardiovascular disease, according to study findings published in Diabetologia.

Survivors of childhood cancer are more likely to have prediabetes at younger ages than the general public, increasing their already elevated risk for diabetes and cardiovascular and kidney diseases, study findings showed.

Adults who lose any amount of weight 1 year after being diagnosed with type 2 diabetes are more likely to achieve diabetes remission than those who gain weight, according to study data published in PLOS Medicine.

Susan Weiner, MS, RDN, CDCES, FADCES, talks with Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, about nuances of using SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes, and a therapy for delaying type 1 diabetes onset.

Pancreatic diabetes may be as prevalent as type 1 diabetes, but knowledge of the disease is lacking. Several research programs are working to change that.

The risk for developing type 2 diabetes is substantially higher for adolescents with overweight or obesity and an HbA1c of at least 6.1% compared with those with an HbA1c of 5.5% or less, according to study data.

Mothers with type 1 or type 2 diabetes have increased risks for having children with a congenital heart defect, according to a study published in JAMA Network Open.

Adults with type 2 diabetes who use GLP-1 receptor agonists do not have an increased short-term risk for pancreatic cancer, according to findings published in JAMA Network Open.

Preliminary results from an ongoing FDA investigation found no evidence that weight-loss drugs cause suicidal ideations and aspirations, although the agency said it cannot rule out a risk entirely.